The CDC is now sequencing about 10,000,000 samples a week and expects to double to 50,000 each week, said Dr. S. K. Krishnan, director of the Advanced Molecular Detection of the FDC’s National Center for Emerging and Zoonotic Infectious Diseases. According to Gregory Armstrong.
Scientists sequence the genome – a complete genetic map of the virus – to find mutations that could affect how the virus spreads.
British scientists have discovered that a new form of the virus has spread there and say that the mutation method transmits it more easily, although it does not cause more serious disease.
It is now available in the U.S. The case has been identified in at least 37 countries, including California, Colorado and Florida.
Armstrong told CNN. “It’s important that we monitor the virus and be able to select trends that could affect public health and clinical medicine,” he said.
To further this order, the CDC gave about 15 15 million to state health laboratories in December. In September and December, the CDC approved about million 1 million for seven university labs and is expected to fund more of the university’s laboratories over the next few months, Armstrong said. He added that the agency has also contracted Illumina and Labcorp, two private labs, to do genomic sequencing.
U.S. Has been criticized for not getting enough virus samples.
Since the onset of the epidemic, the USA has submitted approximately 57,000 genomic sequences to GISAID, the central database used by countries around the world. By comparison, the UK has had far fewer infections but has submitted around 141,000 sequences.
Armstrong notes that the UK and some other countries have a more centralized system for sequencing, while the U.S. In a variety of labs – federal, state, educational and private – are working.
Armstrong said, “It’s a somewhat poppy system.
Results are expected this week from labs studying whether the new variant coronavirus vaccine, first identified in Britain, could pose a challenge, a World Health Organization official said.
U.K. And elsewhere scientists are taking the blood of vaccinated people and testing it in the lab to see if the antibodies created by the vaccine protect against the new variant, the WHO’s technical lead for the corinavirus response. .
They are taking the blood of people infected with the new variant and testing it in the lab, she told CNN, she told CNN.
Pfizer and Moderna, two authorized vaccine manufacturers in the United States, are working in their labs to see if the vaccine is effective against different types of viruses.
On Wednesday, the director of the National Institute of Allergy and Infectious Diseases, Dr. Ant.
The UK variant has 17 variations, which is an unusually large number.
Scientists are also conducting tests in South Africa to evaluate the effectiveness of the vaccine against variants with 22 mutations, Van Kerkov said.